Perceptive Advisors LLC Reduces Stake in Spyre Therapeutics Inc
| SYRE Stock | 21.81 0.01 0.05% |
About 62% of Spyre Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Spyre Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Spyre Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Spyre Therapeutics stock news signals to limit their universe of possible portfolio assets.
Spyre |
Overview of the Recent Transaction On September 30, 2024, Perceptive Advisors LLC executed a significant transaction involving the shares of Spyre Therapeutics
Read at gurufocus.com
 |
Spyre Therapeutics Fundamental Analysis
We analyze Spyre Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spyre Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spyre Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Spyre Therapeutics is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Spyre Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spyre Therapeutics stock to make a market-neutral strategy. Peer analysis of Spyre Therapeutics could also be used in its relative valuation, which is a method of valuing Spyre Therapeutics by comparing valuation metrics with similar companies.
Peers
Spyre Therapeutics Related Equities
| ELVA | Electrovaya Common | 1.11 | ||||
| IPXXU | Inflection Point | 0.78 | ||||
| ALDF | Aldel Financial | 0.10 | ||||
| HNI | HNI Corp | 0.35 | ||||
| PTEN | Patterson UTI | 1.20 | ||||
| NBR | Nabors Industries | 1.35 |
Complementary Tools for Spyre Stock analysis
When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |